Illumina Body Map 2: averaged replicates
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
STAT5B | hg19_v2_chr17_-_40428359_40428462 | -0.23 | 2.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_-_50523843 Show fit | 2.85 |
ENST00000535444.1
ENST00000431262.2 |
megalencephalic leukoencephalopathy with subcortical cysts 1 |
|
chr3_-_151047327 Show fit | 2.84 |
ENST00000325602.5
|
purinergic receptor P2Y, G-protein coupled, 13 |
|
chr22_-_50523807 Show fit | 2.78 |
ENST00000442311.1
ENST00000538737.1 |
megalencephalic leukoencephalopathy with subcortical cysts 1 |
|
chr22_-_50523688 Show fit | 2.58 |
ENST00000450140.2
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
|
chr17_-_26697304 Show fit | 2.31 |
ENST00000536498.1
|
vitronectin |
|
chr1_+_149754227 Show fit | 2.16 |
ENST00000444948.1
ENST00000369168.4 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
chr22_-_50523760 Show fit | 2.09 |
ENST00000395876.2
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
|
chr22_-_37213554 Show fit | 1.98 |
ENST00000443735.1
|
parvalbumin |
|
chr6_+_116782527 Show fit | 1.95 |
ENST00000368606.3
ENST00000368605.1 |
family with sequence similarity 26, member F |
|
chr12_+_21207503 Show fit | 1.94 |
ENST00000545916.1
|
solute carrier organic anion transporter family, member 1B7 (non-functional) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 10.3 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.4 | 5.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.5 | 3.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 3.6 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.2 | 3.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 3.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 2.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 2.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 2.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 2.0 | GO:0006108 | malate metabolic process(GO:0006108) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.5 | GO:0005901 | caveola(GO:0005901) |
0.4 | 5.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 4.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 3.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.6 | 2.3 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 2.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 2.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 1.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 1.6 | GO:0005844 | polysome(GO:0005844) |
0.3 | 1.5 | GO:1990031 | pinceau fiber(GO:1990031) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 4.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 3.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.8 | 3.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 2.8 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 2.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.5 | 2.0 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
0.2 | 1.8 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 1.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 2.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 24.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.3 | 5.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 4.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 3.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 2.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 2.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 2.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 2.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 2.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |